JP2000513013A - ピロロピロロン誘導体 - Google Patents

ピロロピロロン誘導体

Info

Publication number
JP2000513013A
JP2000513013A JP10541320A JP54132098A JP2000513013A JP 2000513013 A JP2000513013 A JP 2000513013A JP 10541320 A JP10541320 A JP 10541320A JP 54132098 A JP54132098 A JP 54132098A JP 2000513013 A JP2000513013 A JP 2000513013A
Authority
JP
Japan
Prior art keywords
compound
formula
alkyl
mmol
fused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10541320A
Other languages
English (en)
Japanese (ja)
Inventor
アラン、デイビッド、ボースウィック
デイビッド、エバン、デイビス
アン、マジョリー、エクサル
デボラ、リネット、ジャクソン
アンドリュー、マクマトリー、メイソン
アンドリュー、マイケル、ケネス、ペネル
サード、ジョージ、ラヒム
ナイミシャ、トリベディ
ゴードン、ガッド、ウェインガーテン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706668.2A external-priority patent/GB9706668D0/en
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719151.4A external-priority patent/GB9719151D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JP2000513013A publication Critical patent/JP2000513013A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
JP10541320A 1997-04-02 1998-04-02 ピロロピロロン誘導体 Pending JP2000513013A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9706668.2A GB9706668D0 (en) 1997-04-02 1997-04-02 Chemical compounds
GB9706668.2 1997-04-02
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GBGB9719151.4A GB9719151D0 (en) 1997-09-09 1997-09-09 Chemical compounds
GB9719189.4 1997-09-09
GB9719151.4 1997-09-09
PCT/GB1998/000982 WO1998043975A1 (fr) 1997-04-02 1998-04-02 Derives de pyrolopyrrolone

Publications (1)

Publication Number Publication Date
JP2000513013A true JP2000513013A (ja) 2000-10-03

Family

ID=27268800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10541320A Pending JP2000513013A (ja) 1997-04-02 1998-04-02 ピロロピロロン誘導体

Country Status (5)

Country Link
EP (1) EP0973775A1 (fr)
JP (1) JP2000513013A (fr)
AU (1) AU6926198A (fr)
CA (1) CA2286367A1 (fr)
WO (1) WO1998043975A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9719161D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd New therapeutic method
GB9821199D0 (en) * 1998-09-30 1998-11-25 Glaxo Group Ltd Chemical compounds
WO2026037721A1 (fr) * 2024-08-14 2026-02-19 Helmholtz-Zentrum für Infektionsforschung GmbH Nouveaux inhibiteurs de cytomegalovirus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003278A1 (fr) * 1993-07-26 1995-02-02 Zaidan Hojin Biseibutsu Kagaku Kenkyukai Derive de pyrrolidine ou sel de celui-ci pharmaceutiquement acceptable

Also Published As

Publication number Publication date
AU6926198A (en) 1998-10-22
EP0973775A1 (fr) 2000-01-26
WO1998043975A1 (fr) 1998-10-08
CA2286367A1 (fr) 1998-10-08

Similar Documents

Publication Publication Date Title
EP3893871B1 (fr) Dérivés de benzimidazolone, et analogues de ceux-ci, en tant que modulateurs d'il-17
CA2537135C (fr) Composes pyrimidothiophene
US9447100B2 (en) Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents
US6479527B1 (en) Bicyclic pyrrole derivatives as MCP-1 inhibitors
AU744014B2 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
HUP0300527A2 (hu) Pirrolopirimidinon-származékok, a vegyületek előállítása és alkalmazása
US5055464A (en) Benzolactam compounds and pharmaceutical uses thereof
CA2692085A1 (fr) Derives de thiazole fusionne comme inhibiteurs de kinase
EP3833671A1 (fr) Thiénopyrroles substitués en tant qu'inhibiteurs de pad4
IL134961A (en) Coltistokinin (CCK) agonist-converted thiazoles, a process for their preparation, pharmaceutical preparations containing them and their use
HUT71354A (en) Perhydroisoindole derivatives as p substance antagonists
HUP0104280A2 (hu) Dopamin D3 receptorok modulátoraiként felhasználható tetrahidrobenzazepin-származékok, eljárás az előállításukra, a vegyületeket tartalmazó gyógyszerkészítmények
JP4118337B2 (ja) 好中球エラスターゼのインヒビターとしてのピロロピロロン誘導体
AU722650B2 (en) Naphthyridine derivatives and their analogues inhibiting cytomegalovirus
KR20050099525A (ko) 피롤로트리아진 키나제 억제제의 제조 방법
SK3192000A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
JP5159630B2 (ja) 縮環複素環誘導体
KR101577314B1 (ko) 키나제 억제제로서의 접합된 티아졸 유도체
JP2000513013A (ja) ピロロピロロン誘導体
HUT54162A (en) Process for producing new substituted thienopyran derivatives and pharmaceutical compositions comprising such compounds
US20040014753A1 (en) Novel interleukin-1beta converting enzyme inhibitors
CN114746087A (zh) 新的经取代的亚砜亚胺衍生物
SK3242000A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
WO2000018770A1 (fr) Derives de pyrrolopyrrolone comme agents antiviraux
JP2001233875A (ja) ピリミジン−５−カルボキサミド化合物、その製造法およびその用途